Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals
- 1 February 1996
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (2) , 197-204
- https://doi.org/10.1016/s0002-9343(97)89459-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Combination Drug Therapy for HypercholesterolemiaArchives of internal medicine (1960), 1993
- Prevalence of High Blood Cholesterol Among US AdultsJAMA, 1993
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veteransThe American Journal of Cardiology, 1993
- Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins.Circulation, 1992
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisPublished by American Medical Association (AMA) ,1990
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- The Value of Lowering Cholesterol after Myocardial InfarctionNew England Journal of Medicine, 1990
- Published by Massachusetts Medical Society ,1990
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984